Our mission is to become an innovative supplier of high-tech digital and communication devices by providing value added design, world-class manufacturing, and service capabilities for cdhe-antobody, ABPP ELISA kit, Ephexin-1 antobody, DND antobody, CD63 Antigen (Melanoma 1 Antigen) antobody. We warmly welcome merchants from your home and overseas to contact us and set up business enterprise partnership with us, and we'll do our greatest to serve you.We have been sincerely looking forward to cooperate with customers all over the world. We believe we can satisfy you with our high-quality products and solutions and perfect service . We also warmly welcome customers to visit our company and purchase our products. LAMP-3 antobody, CDCBM1 antobody, CFEOM3A antobody, Apoptosis-Associated Speck-Like antobody.
AREX Biosciences is proud to announce the launch of our new ELISA (Enzyme-Linked Immunosorbent Assay) series, designed for the quantitative measurement of target proteins in various biological samples, including serum, plasma, cell culture supernatants, u
Hangzhou, China – July 19, 2024 – AREX Biosciences Ltd. is excited to announce that it has been officially appointed as the authorized distributor for arigo Biolaboratories Corp. in China. This partnership is set to run from July 19, 2024, to
arigo is proud to introduce arigoPLEX® product line Multiplex ELISA Kits thatallow detection of four or eightcytokines simultaneously.lt makes thecomplex quantification of multiplecytokines easy and efficient.
Hangzhou, China – July 2024 – AREX Biosciences Ltd. is pleased to announce its collaboration with two prominent life sciences companies, arigo Biolaboratories Corp. and RevMAb Biosciences USA Inc., to increase the accessibility of high-quality
Product variety is complete, good quality and inexpensive, the delivery is fast and transport is security, very good, we are happy to cooperate with a reputable company!
This manufacturers not only respected our choice and requirements, but also gave us a lot of good suggestions, ultimately, we successfully completed the procurement tasks.